NL-OMON35633撤回3 期
altrexone as anti-craving medication in cannabis addicts - Naltrexone in cannabis addiction
Centrum Maliebaan (Utrecht)0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •male or female
- •between 18 - 60 years old
- •current primary diagnosis of cannabis abuse or dependence
- •able to provide written informed consent and to comply with all study procedures
排除标准
- •currently dependent on opiates
- •currently majorly dependant on another substance other than cannabis or nicotine
- •severe medical illness
- •known allergy to Naltrexone
研究者
相似试验
招募中
不适用
altrexone as anti-craving medication in cannabis addicts.cannabis addictionNL-OMON28347Centrum MaliebaanBezoekadres:Tolsteegsingel 2a3582 AC UtrechtPostadres:Postbus 141163508 SE Utrecht tel. algemeen: 030-234 00 34fax: 030-233 29 8060
进行中（未招募）
1 期
altrexone Enhanced Addiction Treatment (NEAT): A randomised controlled trial of the clinical and cost-effectiveness of extended-release naltrexone and oral naltrexoneEUCTR2013-002584-25-GBKing's College London6
已完成
不适用
altrexone Enhanced Addiction Treatment (NEAT)ISRCTN95809946King's College London300
进行中（未招募）
不适用
Effect of Naltrexone on cue-induced craving for Amphetamine in amphetamine dependent individualsEUCTR2006-000837-36-SEBeroendecentrum Stockholm
尚未招募
4 期
To compare the anti-craving effect of three drugs Naltrexone, Topiramate and Baclofen in patients using alcohol.CTRI/2019/05/019346SGT University